Post-exercise changes in myostatin and actRIIB expression in obese insulin-resistant rats

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 159-164

  Bueno, P G ^a   Bassi, D ^b   Contrera, D G ^a   Carnielli, H M ^a   Silva, R N ^b   Nonaka, K O ^a   Selistre de Araujo H S ^a   Leal, A M O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Exercise; Myostatin; Obesity

Indexed keywords

INSULIN; MESSENGER RNA; MYOSTATIN; PROTEIN ACTRIIB; RECEPTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; GENE EXPRESSION; GENE LOCATION; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SKELETAL MUSCLE;

ACTIVIN RECEPTORS, TYPE II; ADIPOSE TISSUE, BROWN; ADIPOSITY; ANIMALS; AREA UNDER CURVE; BODY WEIGHT; DIETARY FATS; EPIDIDYMIS; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MESENTERIC ARTERIES; MUSCLE, SKELETAL; MYOSTATIN; OBESITY; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR;

EID: 79958059536     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.006     Document Type: Article

References (49)

1. Allen D.L., Cleary A.S., Speaker K.J., Lindsay S.F., Uyenishi J., Reed J.M., Madden M.C., Mehan R.S. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E918-927.
2. Artaza J.N., Bhasin S., Magee T.R., Reisz-Porszasz S., Shen R., Groome N.P., Meerasahib M.F., Gonzalez-Cadavid N.F. Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 2005, 146:3547-3557.
3. Bruce C.R., Hawley J.A. Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Med. Sci. Sports Exerc. 2004, 36:1196-1201.
4. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
5. Chalkley S.M., Hettiarachchi M., Chisholm D.J., Kraegen E.W. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1231-1238.
6. Chen Y., Ye J., Cao L., Zhang Y., Xia W., Zhu D. Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int. J. Biochem. Cell Biol. 2010, 42:2072-2081.
7. Debieve F., Hinck L., Biard J.M., Bernard P., Hubinont C. Activin receptor expression and induction of apoptosis in rat blastocysts in vitro. Human Reprod. 2006, 21:618-623.
8. Dilger A.C., Spurlock M.E., Grant A.L., Gerrard D.E. Myostatin null mice respond differently to dietary-induced and genetic obesity. Animal Sci. J. 2010, 81:586-593.
9. Federico A., D'Aiuto E., Borriello F., Barra G., Gravina A.G., Romano M., De Palma R. Fat: a matter of disturbance for the immune system. World J. Gastroenterol. 2010, 16:4762-4772.
10. Feldman B.J., Streeper R.S., Farese R.V., Yamamoto K.R. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc. Natl. Acad. Sci. U S A 2006, 103:15675-15680.
11. Garma T., Kobayashi C., Haddad F., Adams G.R., Bodell P.W., Baldwin K.M. Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise. J. Appl. Physiol. 2007, 102:135-143.
12. Guerra R.L., Prado W.L., Cheik N.C., Viana F.P., Botero J.P., Vendramini R.C., Carlos I.Z., Rossi E.A., Damaso A.R. Effects of 2 or 5 consecutive exercise days on adipocyte area and lipid parameters in Wistar rats. Lipids Health Dis. 2007, 6:16.
13. Guo T., Jou W., Chanturiya T., Portas J., Gavrilova O., McPherron A.C. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009, 4:e4937.
14. Hamann A., Flier J.S., Lowell B.B. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 1996, 137:21-29.
15. Hamrick M.W., Samaddar T., Pennington C., McCormick J. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J. Bone Miner Res. 2006, 21:477-483.
16. Heinemeier K.M., Olesen J.L., Schjerling P., Haddad F., Langberg H., Baldwin K.M., Kjaer M. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J. Appl. Physiol. 2007, 102:573-581.
17. Hill J.J., Davies M.V., Pearson A.A., Wang J.H., Hewick R.M., Wolfman N.M., Qiu Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 2002, 277:40735-40741.
18. Hittel D.S., Axelson M., Sarna N., Shearer J., Huffman K.M., Kraus W.E. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med. Sci. Sports Exerc. 2010, 42:2023-2029.
19. Hittel D.S., Berggren J.R., Shearer J., Boyle K., Houmard J.A. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 2009, 58:30-38.
20. Hulmi J.J., Ahtiainen J.P., Kaasalainen T., Pollanen E., Hakkinen K., Alen M., Selanne H., Kovanen V., Mero A.A. Postexercise myostatin and activin IIb mRNA levels: effects of strength training. Med. Sci. Sports Exerc. 2007, 39:289-297.
21. Hutchinson D.S., Chernogubova E., Dallner O.S., Cannon B., Bengtsson T. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005, 48:2386-2395.
22. Kim H.S., Liang L., Dean R.G., Hausman D.B., Hartzell D.L., Baile C.A. Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures. Biochem. Biophys. Res. Commun. 2001, 281:902-906.
23. Konopka A.R., Douglass M.D., Kaminsky L.A., Jemiolo B., Trappe T.A., Trappe S., Harber M.P. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J. Gerontol. A Biol. Sci. Med. Sci. 2010.
24. Lee S.J., Reed L.A., Davies M.V., Girgenrath S., Goad M.E., Tomkinson K.N., Wright J.F., Barker C., Ehrmantraut G., Holmstrom J., Trowell B., Gertz B., Jiang M.S., Sebald S.M., Matzuk M., Li E., Liang L.F., Quattlebaum E., Stotish R.L., Wolfman N.M. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. U S A 2005, 102:18117-18122.
25. Lin J., Arnold H.B., Della-Fera M.A., Azain M.J., Hartzell D.L., Baile C.A. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 2002, 291:701-706.
26. Lyons J.A., Haring J.S., Biga P.R. Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice. PLoS One 2010, 5:e12928.
27. Matsakas A., Bozzo C., Cacciani N., Caliaro F., Reggiani C., Mascarello F., Patruno M. Effect of swimming on myostatin expression in white and red gastrocnemius muscle and in cardiac muscle of rats. Exp. Physiol. 2006, 91:983-994.
28. Matsakas A., Friedel A., Hertrampf T., Diel P. Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat. Acta Physiol. Scand. 2005, 183:299-307.
29. McPherron A.C. Metabolic functions of myostatin and Gdf11. Immunol. Endocr. Metab. Agents Med. Chem. 2010, 10:217-231.
30. McPherron A.C., Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. U S A 1997, 94:12457-12461.
31. McPherron A.C., Lee S.J. Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Invest. 2002, 109:595-601.
32. Milan G., Dalla Nora E., Pilon C., Pagano C., Granzotto M., Manco M., Mingrone G., Vettor R. Changes in muscle myostatin expression in obese subjects after weight loss. J. Clin. Endocrinol. Metab. 2004, 89:2724-2727.
33. Mukherjee A., Sidis Y., Mahan A., Raher M.J., Xia Y., Rosen E.D., Bloch K.D., Thomas M.K., Schneyer A.L. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. U S A 2007, 104:1348-1353.
34. Oh K.S., Kim E.Y., Yoon M., Lee C.M. Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activating uncoupling proteins. Exp. Mol. Med. 2007, 39:385-394.
35. Palsgaard J., Brons C., Friedrichsen M., Dominguez H., Jensen M., Storgaard H., Spohr C., Torp-Pedersen C., Borup R., De Meyts P., Vaag A. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 2009, 4:e6575.
36. Park J.J., Berggren J.R., Hulver M.W., Houmard J.A., Hoffman E.P. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol. Genomics 2006, 27:114-121.
37. Pauli J.R., Ropelle E.R., Cintra D.E., Carvalho-Filho M.A., Moraes J.C., De Souza C.T., Velloso L.A., Carvalheira J.B., Saad M.J. Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats. J. Physiol. 2008, 586:659-671.
38. Raue U., Slivka D., Jemiolo B., Hollon C., Trappe S. Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J. Appl. Physiol. 2006, 101:53-59.
39. Rebbapragada A., Benchabane H., Wrana J.L., Celeste A.J., Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell Biol. 2003, 23:7230-7242.
40. Redinger R.N. Fat storage and the biology of energy expenditure. Transl. Res. 2009, 154:52-60.
41. Tseng Y.H., Kokkotou E., Schulz T.J., Huang T.L., Winnay J.N., Taniguchi C.M., Tran T.T., Suzuki R., Espinoza D.O., Yamamoto Y., Ahrens M.J., Dudley A.T., Norris A.W., Kulkarni R.N., Kahn C.R. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008, 454:1000-1004.
42. Tu P., Bhasin S., Hruz P.W., Herbst K.L., Castellani L.W., Hua N., Hamilton J.A., Guo W. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes 2009, 58:1739-1748.
43. Vila-Bedmar R., Lorenzo M., Fernandez-Veledo S. Adenosine 5′-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 2010, 151:980-992.
44. Welt C., Sidis Y., Keutmann H., Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 2002, 227:724-752.
45. Wilkes J.J., Lloyd D.J., Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009, 58:1133-1143.
46. Woods S.C., Seeley R.J., Rushing P.A., D'Alessio D., Tso P. A controlled high-fat diet induces an obese syndrome in rats. J. Nutr. 2003, 133:1081-1087.
47. Yaspelkis B.B., Lessard S.J., Reeder D.W., Limon J.J., Saito M., Rivas D.A., Kvasha I., Hawley J.A. Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E941-949.
48. Zhao B., Wall R.J., Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem. Biophys. Res. Commun. 2005, 337:248-255.
49. Zimmers T.A., Davies M.V., Koniaris L.G., Haynes P., Esquela A.F., Tomkinson K.N., McPherron A.C., Wolfman N.M., Lee S.J. Induction of cachexia in mice by systemically administered myostatin. Science 2002, 296:1486-1488.